ARTICLE | Clinical News
H regulatory update
October 25, 2010 7:00 AM UTC
FDA approved an sNDA from Questcor for H.P. Acthar Gel to prevent infantile spasms (IS). Questcor already markets the adrenocorticotropic hormone injection to treat acute exacerbations of multiple scl...